Thyroid No Surgery 101: How to Avoid Major Thyroid Eye Surgery for Graves ‘Eye disease TED
A new drug for thyroid eye disease is now in Phase 3 trials.
It is called Teprotumumab. It has been classified as a breakthrough therapy for thyroid eye disease. This will expedite the review of drugs that could treat serious conditions.
TED is a serious disease condition of the eyes in some with hyperthyroid Graves’ disease patients.
Suffering with bulging eyes with is associated with many side effects and can lead to major surgery called orbital decompression.
This drug has shown the ability to decrease bulging eyes and relieve double vision, and increase quality of life for the patients.
This drug is only available through clinical trials.
See if you are a candidate at:
NCT # 03298867
If you are planning a surgery try this first unless it is an emergency with loss of vision.
Richard Guttler Md.FACE.ECNU